However, the number of mutation techniques and non-synonymous mutations demonstrated an increasing trend in the low GIS group, but it was not significant ( Figures 6B,C ).
← all excerpts
Development and validation of a combined glycolysis and immune prognostic signature for lung squamous cell carcinoma.
1
—
—